PACIRA BIOSCIENCES, INC. Income Taxes Paid
PACIRA BIOSCIENCES, INC. (PCRX) reported Income Taxes Paid of $11.02 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2025-02-27
- PACIRA BIOSCIENCES, INC. income taxes paid for the quarter ending 2015-12-31 was $194.80K, a 472.94% increase year-over-year.
- PACIRA BIOSCIENCES, INC. income taxes paid for the quarter ending 2015-09-30 was $40.00.
- PACIRA BIOSCIENCES, INC. income taxes paid for the quarter ending 2015-06-30 was -$1.00.
- PACIRA BIOSCIENCES, INC. income taxes paid for the quarter ending 2015-03-31 was $160.00.
- PACIRA BIOSCIENCES, INC. income taxes paid for fiscal 2024 was $11.02M, a 152.43% increase from fiscal 2023.
- PACIRA BIOSCIENCES, INC. income taxes paid for fiscal 2023 was $4.37M, a 40.98% decline from fiscal 2022.
- PACIRA BIOSCIENCES, INC. income taxes paid for fiscal 2022 was $7.40M, a 129.68% increase from fiscal 2021.
- PACIRA BIOSCIENCES, INC. income taxes paid for fiscal 2021 was $3.22M, a 33.26% increase from fiscal 2020.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2024-12-31 | $11.02M 10-K · filed 2025-02-27 | |||
| 2023-12-31 | $4.37M 10-K · filed 2025-02-27 | |||
| 2022-12-31 | $7.40M 10-K · filed 2025-02-27 | |||
| 2021-12-31 | $3.22M 10-K · filed 2024-02-29 | |||
| 2020-12-31 | $2.42M 10-K · filed 2023-02-28 | |||
| 2019-12-31 | $863.00K 10-K · filed 2022-02-28 | |||
| 2018-12-31 | $128.00K 10-K · filed 2021-03-01 | |||
| 2017-12-31 | $129.00K 10-K · filed 2020-02-21 | |||
| 2016-12-31 | $247.00K 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $194.80K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $194.84K derived: sum of 2 quarters · filed 2018-02-28 | $194.84K derived: sum of 3 quarters · filed 2018-02-28 | $195.00K 10-K · filed 2018-02-28 |
| 2015-09-30 | $40.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $39.00 derived: sum of 2 quarters · filed 2015-10-27 | $199.00 10-Q · filed 2015-10-27 | $34.20K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $159.00 10-Q · filed 2015-07-30 | $34.16K derived: sum of 3 quarters · filed 2017-03-01 | $34.16K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $160.00 10-Q · filed 2015-04-30 | $34.16K derived: sum of 2 quarters · filed 2017-03-01 | $34.16K derived: sum of 3 quarters · filed 2017-03-01 | $34.16K derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $34.00K 10-K · filed 2017-03-01 | $34.00K derived: sum of 2 quarters · filed 2017-03-01 | $34.00K derived: sum of 3 quarters · filed 2017-03-01 | $34.00K 10-K · filed 2016-02-25 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $0.00 derived: sum of 2 quarters · filed 2015-10-27 | $0.00 10-Q · filed 2015-10-27 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $0.00 10-Q · filed 2015-07-30 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-04-30 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-02-25 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |